An issue of Pharmaceutical Product Development Inc (NASDAQ:PPDI) bonds fell 1.1% as a percentage of their face value during trading on Friday. The debt issue has a 6.375% coupon and will mature on August 1, 2023. The debt is now trading at $104.50 and was trading at $104.75 one week ago. Price moves in a company’s bonds in credit markets sometimes predict parallel moves in its stock price.
Pharmaceutical Product Development Company Profile
Pharmaceutical Product Development, Inc is a global contract research organization providing drug discovery and development services. Its clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. Its development services include preclinical programs and Phase I through Phase IV clinical development services, as well as bioanalytical, cGMP, global central laboratory and vaccines and biologics laboratory services.
Receive News & Ratings for Pharmaceutical Product Development Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharmaceutical Product Development Inc and related companies with MarketBeat.com's FREE daily email newsletter.